The Company and Tacora entered into a stock purchase agreement dated as of September 25, 2023 Pursuant to the terms of the Stock Purchase Agreement, on the Closing Date, the Company sold to Tacora: (i) 7,578 shares of common stock, par value $0.01 (ii) 13,725 shares of Series B Preferred Stock, par value $0.01 (iii) 7,500 Series 1 restricted stock units (iv) 15,000 Series 2 restricted stock units.